Results 131 to 140 of about 13,248 (184)

Clinical Emergence and Genomic Characterization of Aztreonam-Avibactam-Resistant <i>Escherichia coli</i> ST410 Isolates in China. [PDF]

Antibiotics (Basel)
Li X, Li P, Feng J, Fang Z, Liu S, Guo C, Hu B.   +6 more
europepmc   +1 more source

Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam. [PDF]

Antimicrob Agents Chemother
Feng C.
europepmc   +1 more source

In vitro activity of aztreonam–avibactam combination against blood culture isolates of Stenotrophomonas maltophilia in Japan before the launch of ceftazidime–avibactam

Microbiology Spectrum
Wataru Aoki, Yoshifumi Uwamino, Yuka Kamoshita, Rika Inose, Mika Nagata, Naoki Hasegawa, Hiromichi Matsushita   +6 more
doaj   +1 more source

Reply to Feng, "Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam". [PDF]

Antimicrob Agents Chemother
Jousset AB, Girlich D, Oueslati S, Birer A, Delaval A, Guyot C, Rezzoug I, Emeraud C, Naas T, Bonnin RA, Dortet L.   +10 more
europepmc   +1 more source

Severe hypokalemia induced by ceftazidime-avibactam: Case report. [PDF]

Medicine (Baltimore)
Yuan Y, Gu Y, Bai W, Liu W, Li W, Yin Y.
europepmc   +1 more source

Cefiderocol nonsusceptibility among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i>: data from the 2024 Antimicrobial Testing Leadership and Surveillance (ATLAS) program. [PDF]

Antimicrob Agents Chemother
Chiu P-W, Wang J-L, Hsueh S-C, Lee N-Y, Huang Y-T, Ko W-C, Hsueh P-R.   +6 more
europepmc   +1 more source

<i>In vitro</i> susceptibility of <i>Stenotrophomonas maltophilia</i> and other carbapenem non-susceptible Gram-negative rods in the Pacific Northwest to cefiderocol and aztreonam-avibactam. [PDF]

JAC Antimicrob Resist
Bryan A, Shields-Pruiett M, Berger H, Fang FC, Penewit K, Waalkes A, Holmes EA, Salipante SJ, Werth BJ.   +8 more
europepmc   +1 more source

Repeated insertions at positions 261-280 in KPC-2 highlight a ceftazidime-avibactam resistance hotspot. [PDF]

iScience
Li Y, Salman S, Liu R, Wang K, Gong L, Sun T, Xu H.   +6 more
europepmc   +1 more source

In vitro activity of aztreonam/avibactam and comparators against Enterobacterales isolates from patients with hospital-acquired pneumonia, ventilator-associated pneumonia, and complicated intra-abdominal infections (ATLAS, 2021-2022). [PDF]

J Antimicrob Chemother
Yang Q, Tuon FF, Shah S, Kamat S, Mohamed N, Stone GG, Perez KK, Cantón R.   +7 more
europepmc   +1 more source

Use of Ceftazidime-Avibactam in a Late-Preterm Newborn with Multidrug-Resistant <i>Enterobacter hormaechei</i> Sepsis. [PDF]

Antibiotics (Basel)
Trizzino M, Notarbartolo V, Pipitò L, Serra G, Romanin B, Carta M, Insinga V, Di Pace MR, Fasciana TMA, Cascio A, Giuffrè M.   +10 more
europepmc   +1 more source